Abbott Reports Second-Quarter 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
Go back to Abbott Reports Second-Quarter 2025 Results
July 18, 2025 10:03 AM EDT
Citi analyst Joanna Wuensch lowered the price target on Abbott Labs (NYSE: ABT) to $155.00 (from $157.00) while maintaining a Buy rating.
The analyst comments "This was a somewhat precarious setup for ABT heading into the quarter, priced for a beat-and-raise, which did not... More
July 17, 2025 9:45 AM EDT
Goldman Sachs analyst David Roman reiterated a Buy rating and $153.00 price target on Abbott Labs (NYSE: ABT).
The analyst comments "This morning, Abbott reported 2Q25 results and updated 2025 guidance. The headline that we expect to gain most attention is the reduction to the... More
July 17, 2025 7:31 AM EDT
Abbott (NYSE: ABT) reported Q2 EPS of $1.26, $0.01 better than the analyst estimate of $1.25. Revenue for the quarter came in at $11.42 billion versus the consensus estimate of $11.07 billion.
GUIDANCE:
Abbott sees FY2025 EPS of $5.10-$5.20, versus the consensus of $5.16.
For earnings history and earnings-related data on Abbott (ABT) click here.
...
More
